News

Wong’s discoveries and technologies have fundamentally shaped our understanding of complex carbohydrates and glycoproteins, as well as uncovered new therapeutic strategies to treat major diseases.

Experimental approach could uncover new treatment options for the virus, which is highly prevalent in Western Africa.

Mendoza’s research focuses on the interwoven circuits that drive inflammation, pain and immunological diseases.

Scripps Research discovery could offer new methods for treating HIV, while uncovering the innate immune system’s role in other diseases.

New tools developed at Scripps Research and UC San Diego are helping public health officials around the world get vital information about pathogen variants from wastewater.

Recognizing outstanding innovators younger than 35, the annual list examines not just where technology is now, but where it’s going and who’s taking it there.

Finding could lead to better drug treatments for chronic itch conditions, like eczema.

A drug discovery approach developed by Scripps Research scientists—in part inspired by oil companies—revealed why drugs for cystic fibrosis fall short

Award honors Sharpless’ pioneering work on “click chemistry”.

Scripps Research scientists discovered that a mutation in the touch-sensitive PIEZO1 ion channel impacts tendon biology and boosts the physical performance of mice.

Open science collaboration will support global genomic surveillance efforts to track coronavirus variants.

Scripps Research scientists find evidence that the immune protein CSF1 may contribute to feelings of anxiety during alcohol withdrawal.

Certain antibodies isolated from people who had recovered from COVID-19 and were vaccinated have the ability to neutralize variety of coronaviruses.

The research could also help better understand other neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s.

Chemists’ technique for turning cheap dicarboxylic acids into complex lactones could boost industries from pharmaceuticals to plastics.

Experimental drug 3K3A-APC showed promising effects in earlier clinical trial.

The multidisciplinary center will focus on development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.

Miller brings a wealth of experience in genome editing to accelerate potential therapeutics for genetic diseases.

Scripps Research scientists develop a sophisticated platform for building and modifying proteoglycans to dissect their normal roles and their roles in diseases, including cancers.

Scripps Research scientists found the chemical binds to opioid receptors in the brain and may have utility as an antidepressant or anti-anxiety drug.

The antibody, already in clinical trials to treat COVID-19, may be effective against future variants.

By restoring the light-sensing function of human retinas hours after death, Scripps Research and collaborators reveal a new way to study age-related macular degeneration and other eye disorders.

Prestigious appointment will support his innovative imaging techniques and investigations into the relationship between metabolism and neurons.

“Pytheas” app created by a team at Scripps Research allows scientists to identify and quantify modified RNA molecules more easily than ever.